Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$866,095,157
+$63,911,225 QoQ
Shares Held
3,543,181
-8.6% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83.87257100328772.ToString("F0")%
Shared 0.ToString("F0")%
None 16.127428996712275.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $5,739,029,995 across 16 Drug Manufacturers - General names. JNJ ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
29,631,105 | $1,797,126,513 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,628,486 | $1,037,920,575 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
3,543,181 | $866,095,157 | |
| 4 | LLY |
ELI LILLY & Co
|
855,420 | $786,789,649 | |
| 5 | BIIB |
Biogen Inc.
|
1,923,557 | $352,645,701 | |
| 6 | PFE |
Pfizer Inc
|
11,879,235 | $333,568,912 | |
| 7 | ABBV |
AbbVie Inc.
|
888,913 | $193,329,684 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,164,803 | $162,338,589 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $866,095,157 | 3,543,181 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $802,183,932 | 3,876,221 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $802,210,727 | 4,326,452 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $732,510,943 | 4,795,489 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $873,265,343 | 5,265,710 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $502,212,471 | 3,472,635 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $511,941,541 | 3,158,963 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $489,678,677 | 3,350,292 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $382,474,153 | 2,417,815 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $293,418,846 | 1,872,010 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $234,564,639 | 1,506,033 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $250,831,986 | 1,515,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $308,543,465 | 1,990,603 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $326,155,784 | 1,846,339 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $326,258,671 | 1,997,176 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $372,360,774 | 2,097,689 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $528,144,690 | 2,979,996 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $510,823,572 | 2,986,050 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $491,892,016 | 3,045,771 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $513,112,052 | 3,114,678 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $674,191,145 | 4,102,167 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $677,137,836 | 4,302,566 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $714,403,210 | 4,798,517 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $748,572,785 | 5,322,995 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $792,316,831 | 6,042,224 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||